An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates by unknown
ORIGINAL ARTICLE
An hour-specific transcutaneous bilirubin nomogram
for Mongolian neonates
Moe Akahira-Azuma1 & Naohiro Yonemoto2 & Rintaro Mori3 & Shinichi Hosokawa1 &
Takeji Matsushita1 & Khulan Sukhbat4 & Gerelmaa Nansal4 &
Bayasgalantai Bavuusuren4 & Enkhtur Shonkhuuz4
Received: 11 February 2015 /Revised: 29 March 2015 /Accepted: 1 April 2015 /Published online: 14 April 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Transcutaneous bilirubin (TcB) nomograms have
been developed for different populations. However, the
TcB level, rate of rise and peak varies among countries
and ethnicities. The aim of this study was to establish an
hour-specific TcB nomogram for healthy term and late pre-
term Mongolian neonates during the first 144 h after birth.
A total of 5084 TcB measurements from 1297 healthy ne-
onates (gestational age ≥35 weeks, birth weight ≥2000 g)
were obtained from October 2012 to October 2013. All
measurements were performed using the Jaundice Meter,
the JM-103 at 6 to 144 postnatal hours. Mongolian infants
had the following characteristics: 27.1 % were delivered by
cesarean section, 17.8 % had a birth weight >4000 g, and
>90 % were being breastfed. TcB percentiles for each des-
ignated time point were calculated for the development of
an hour-specific nomogram. TcB levels increased most
rapidly in the first 24 h and less rapidly from 24 to 78 h,
reaching a plateau after 78 h for the 50th percentile. TcB
levels of Mongolian neonates for each time point were
higher than those of previous studies.
Conclusion: The higher values of the TcB nomogram for
Mongolian neonates may be due to their Asian ethnicity and
exclusive breastfeeding.
What is Known:
• TcB nomograms for neonatal jaundice screening have been established
for many countries and ethnicities. The pattern of the TcB nomogram
varies by country and ethnicity.
What is New:
• A TcB nomogram for neonates of Mongolian ethnicity at 6–144
postnatal hours was created and it had higher values than those in
previous studies.
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Introduction
Neonatal hyperbilirubinemia and neurological sequelae
resulting from kernicterus pose a serious medical burden in
both developing and developed countries [13, 15, 16, 23].
However, severe hyperbilirubinemia in the newborn is prevent-
able through appropriate follow-up, diagnosis, and treatment,
such as phototherapy and exchange transfusions [8, 9, 13, 23].
The American Academy of Pediatrics (AAP) recommends that
all neonates undergo total serum bilirubin (TSB) or transcuta-
neous bilirubin (TcB) measurements at least once before hos-
pital discharge to assess their risk of hyperbilirubinemia [2, 17].
TcB nomogram is a use fu l too l for neonata l
hyperbilirubinemia screening [10]. However, the TcB value,
rate of rise and peak varies with country and ethnicity [5],
suggesting that each country and ethnic group has specific
risk factors for hyperbilirubinemia. Few studies on the TcB
nomogram have been done for Mongolian neonates in a
resource-limiting setting [1].
The aim of this study was to create an hour-specific TcB
nomogram for healthy Mongolian neonates, which was




This was a prospective cohort study at the National Center for
Maternal and Child Health (NCMCH), a tertiary care hospital
in Ulaanbaatar, Mongolia. Neonates who were eligible for
enrollment were healthy newborns ≥35 weeks of gestation
with a birth weight ≥2000 g who were delivered in the hospital
on a weekday (from Monday to Friday morning) and whose
address were in the Bayangol district. Exclusion criteria in-
cluded the following: infants with birth asphyxia, respiratory
distress, NICU admission, congenital infection, Rh
isoimmunization, jaundice within 24 h of birth, skin infection,
congenital spinal anomaly, those with no TcB measurement,
and cases with missing information. The study was carried out
from October 15, 2012 to October 4, 2013 but was temporar-
ily suspended between June 28 and August 2, 2013 when the
maternity unit was closed for renovation. Perinatal informa-
tion on the mother and infant were extracted from their
medical charts including sex, gestational age, birth weight,
mode of delivery, duration of hospitalization, maternal age,
parity, gravidity, maternal blood type, family history of sib-
lings, and feeding type before and after discharge.
This study was approved by the NCMCH ethics committee
in Mongolia and the National Center for Global Health and
Medicine (NCGM) human investigation ethics committee in
Japan, in accordance with the Declaration of Helsinki. In-
formed consent was obtained from all individual participants
(mothers of the infants) included in the study.
Measurements
TcB measurements were performed between 9 am and 5 pm
twice daily (once in the morning and once in evening) from
Monday to Friday. The Jaundice Meter JM-103 (Konica
Minolta, Osaka, Japan) was used by properly trained pediatri-
cians or a research technician to measure TcB. The operation
of the JM-103 and its measurement technique have been de-
scribed previously [1]. Briefly, TcB levels were measured at
the forehead and at the midsternum three times at each site,
and the median value was defined as the TcB at each measure-
ment site. The highest value of two sites was used as the TcB
for each infant. Because NCMCH applies a discharge policy
of ≥48 h for vaginally delivered infants and ≥72 h for those
delivered by cesarean section, the parents were advised to
return to the outpatient clinic for follow-up measurements.
Enrolled neonates returned for a follow-up visit between days
3–6 or earlier if the parents noticed worsening jaundice in their
child. Parents who did not bring their child for the visit were
reminded by telephone. An enrollment number was given to
each neonate and recorded in a log book to identify the study
neonate during the visit. TcB values were recorded on a flow
sheet designed for the study and attached to the signed in-
formed consent form in the medical record of each infant.
Fig. 1 Study flow
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TcB measurements obtained at 6±2 h intervals up to 144 h
were examined [12, 18]. TcB measurements not taken be-
tween these time measurements were omitted from analysis.
The decision regarding the need for phototherapy was made
by the attending pediatrician based on TSB levels, in accor-
dance with NCMCH’s protocol and/or AAP guidelines [2]. If
Table 1 Characteristics of the
enrolled neonates and their
mothers
Characteristic n=1297 (%)
1. Sex Male 662 (51.0)
Female 635 (49.0)
2. Gestational age 35–36 weeks 16 (1.2)
37–40 week 1230 (94.9)
41–42 weeks 51 (3.9)
3. Birth weight 2000–2999 g 92 (7.1)
3000–3999 g 975 (75.1)
4000–4999 g 228 (17.6)
>5000 g 2 (0.2)
4. Mode of delivery Vaginal 945 (72.9)
Cesarean section 352 (27.1)
5. Duration of hospitalization 1–2 day (s) 907 (69.9)
3–4 days 355 (27.4)
5–7 days 35 (2.7)
6. Maternal age 15–24 years old 293 (22.6)
25–34 years old 748 (57.7)
35–45 years old 256 (19.7)




5 to 9 139 (10.7)




5 to 9 15 (1.2)





No description 1 (0.1)
10. Family history of siblings First baby 446 (34.4)
Phototherapy 161 (12.4)
Exchange transfusion 2 (0.2)
No jaundice 688 (53.0)
11. Feeding (before discharge) Breastfeeding 1264 (97.4)
Formula 3 (0.2)
Mixed 30 (2.3)
12. Feeding (follow-up visit) No follow-up visit 160
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TcB values were obtained, measurement values obtained after
the initiation of phototherapy were excluded from analysis.
The characteristics of mothers and children are present-
ed as percentages for binary and categorical data, and as
means and standard deviations for continuous data. The data
analysis was performed by using SPSS 15.0 for Windows
(SPSS, Chicago, IL).
TcB percentiles (95th, 90th, 75th, 50th, 25th, 10th, and 5th
percentiles) were calculated for each designated time. A TcB
nomogram with smoothed percentile curves for the period 6–
144 postnatal hours was prepared using Microsoft Excel 2010
(Microsoft, Redmond, WA).
Results
Of 1846 live births in NCMCH during the study period, 549
neonates did not meet the enrollment criteria (Fig. 1), resulting
in 1297 healthy term and late-preterm neonates from whom
5084 TcB measurements were obtained. Among these TcB
measurements, 3487 that were taken at the designated time
were used for analysis. Of the 1297 enrolled neonates, 1137
(87.7 %) returned for the follow-up visit after hospital
discharge.
Demographic and background data of mothers and neo-
nates are summarized in Table 1. Of note, all neonates were
Mongolian, 27.1 % were delivered by a cesarean section,
≥90 % were breastfed, and 17.8 % had a birth weight
≥4000 g. Regarding the family history of jaundice, 851 of
1297 enrolled infants had siblings and 163 of 851 siblings
(19.2 %) had a history of treatment for jaundice according to
an interview with the mother. Details of the jaundice could not
be obtained to clarify the etiology of jaundice.
A TcB nomogram with smoothed percentile curves (95th,
90th, 75th, 50th, 25th, 10th, and 5th percentiles) for the time
period 6–144 postnatal hours is presented in Fig. 2. The num-
bers of TcBmeasurements are shown for each time point. TcB
levels increased in a linear fashion most rapidly in the first
24 h and less rapidly from 24 to 78 h, reaching a plateau after
78 h for the 50th percentile.
Discussion
We created an hour-specific TcB nomogram for the first 144 h
after birth for Mongolian healthy term and late preterm neo-
nates. The characteristics of this group of Mongolian neonates
included delivery by cesarean section in 26.9 % of cases and
exclusive breastfeeding in >90 %. The TcB values and rate of
rise at each designated time point resulted in a TcB nomogram
with higher values than those reported for other countries and
ethnicities in previous studies. This result indicates that this
group might have risk factors and a higher likelihood of de-
veloping neonatal hyperbilirubinemia.
Many TcB nomogram studies have been performed in
North America, Europe, and Asia in different groups [3, 6,
7, 11, 12, 14, 18, 19, 21, 25, 28] since the second generation
of the TcB meter became available. The risk factors of
hyperbilirubinemia were determined to be Asian ethnicity,
exclusive breastfeeding, weight loss, and a sibling with neo-
natal jaundice [17]. In a North American study investigating
an hour-specific TcB nomogram in the first 96 h using the JM-
103 to measure levels in 3984 neonates, 73.1 % were Cauca-
sian, 45.1 % were delivered by cesarean section, and 66.2 %
were breastfed [18]. TcB nomogram for Mongolian neonates
showed much higher values than the North American nomo-
gram at each time point. This might be due to the predominant
Caucasian ethnicity of the study group [22]. In a study on
infants of Asian ethnicity, a TcB nomogram was developed
using JM-103 measurements taken from 6035 Chinese infants
[28]. These Chinese infants were delivered by cesarean sec-
tion in 55.5 % of cases, 25.1 % were breastfed, and 9.4 % had
a birth weight >4000 g. In contrast, our study of Mongolian
neonates showed higher TcB values at each time point, sug-
gesting that exclusive breastfeeding might have contributed to
this result [4]. A recent study on the influence of dehydration
on body weight loss at 72 h after birth in Taiwan revealed the
optimum body weight loss cutoff points for predicting
hyperbilirubinemia [27]. Unfortunately, the body weights on
each day of TcB measurement were not determined in our
study. Therefore, it remains unclear whether the acceleration
of hyperbilirubinemia of Mongolian neonates is caused by
exclusive breastfeeding itself or by dehydration secondary to
inappropriate breastfeeding.
This prospective cohort study was a tertiary hospital-based
study that enrolled neonates from one district, and TcB mea-
surements were done either in the maternity unit or in the
Fig. 2 An hour-specific TcB nomogram for Mongolian neonates with
smoothed curves for the 5th, 10th, 25th, 50th, 75th, 90th, and 95th per-
centiles. Numbers in parentheses indicate the number of TcB measure-
ments at each time point
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outpatient clinic [26]. Our study method for creating a TcB
nomogram is practical and can be applied in countries with
limited resources. This encourages resource-limited countries
to create country- and ethnic-specific TcB nomograms.
This study has several limitations. First, there were insuffi-
cient numbers of TcB measurements at the follow-up visit on
day 3–6, only one to two measurements. Second, the desig-
nated times for TcB measurements were difficult to establish,
leading to the omission of a certain number of TcB measure-
ments. However, it was impossible to fix a designated TcB
measurement time for each neonate in ordinary practice.
Third, the glucose-6-phosphate dehydrogenase (G6PD) and
direct Coombs test are not routinely performed in prenatal care
screening in Mongolia so G6PD deficiency and ABO incom-
patibility could not be ruled out in this group. Fourth,
cephalohematoma, a risk factor for hyperbilirubinemia, might
be increased, considering the high percentage of vaginal de-
liveries and heavy infants (17.8 % had birth weight >4000 g)
[20, 24]. Although cephalohematoma should have been iden-
tified as a risk factor, this does not affect the validity of the
nomogram. Fifth, because infants with significant
hyperbilirubinemia were referred to the hospital for further
work-up and treatment and were later excluded from the
study, the TcBmeasurements and curves we report here might
be lower than the actual TcB values.
The findings in this study contribute to improving appro-
priate diagnosis and treatment of neonatal hyperbilirubinemia,
and might reduce the incidence of neurological impairment in
this high-risk ethnic group.
Conclusion
We provide data on TcB levels for the first 144 postnatal hours
that were derived from a group of Mongolian term and late
preterm neonates. The higher values of the TcB nomogram
derived from Mongolian neonates may be due to their Asian
ethnicity and exclusive breastfeeding.
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